The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of erythropoietin-stimulating agent use on belzutifan antitumor activity in patients with VHL disease–associated renal cell carcinoma: Post hoc analysis of the LITESPARK-004 study.
 
Benjamin L. Maughan
Consulting or Advisory Role - Astellas Medivation; AVEO; Bavarian Nordic; Bayer; Bristol-Myers Squibb; Clovis Oncology; Exelixis; Janssen Oncology; Merck; Peloton Therapeutics; Pfizer; Tempus
Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Ramaprasad Srinivasan
Research Funding - Allogene Therapeutics (Inst); Allogene Therapeutics (Inst); NiKang Therapeutics (Inst); Peloton Therapeutics (Inst)
 
Othon Iliopoulos
Consulting or Advisory Role - Merck
 
Ane Bundsbæk Bøndergaard Iversen
No Relationships to Disclose
 
Vivek Narayan
Honoraria - Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca; Exelixis; Janssen Oncology; Merck; Myovant Sciences; Pfizer/EMD Serono; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst); Tmunity Therapeutics, Inc. (Inst)
 
Stephane Oudard
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; IPSEN,; Janssen; Merck; Novartis; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; IPSEN,; Janssen; Merck; Novartis; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); IPSEN, (Inst); Janssen (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; IPSEN,; Janssen; Merck; Novartis; Sanofi
 
Tobias Else
Consulting or Advisory Role - HRA Pharma; Lantheus Medical Imaging; Merck
Research Funding - Corcept Therapeutics
 
Jodi K. Maranchie
Research Funding - Coimmune (Inst); Exelixis (Inst); Janssen (Inst); Merck (Inst)
 
Katy Beckermann
Consulting or Advisory Role - Alpine Immune Sciences; Aravive; AstraZeneca; AVEO; Bristol-Myers Squibb; Exelixis; Merck; Sanofi; Seagen
Research Funding - Aravive (Inst); ArsenalBio (Inst); Bristol-Myers Squibb; Merck Sharp & Dohme; Pionyr (Inst)
 
Wei Fu
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Rodolfo F. Perini
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Yanfang Liu
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
W. Marston Linehan
No Relationships to Disclose
 
Eric Jonasch
Consulting or Advisory Role - Aveo; Eisai; Exelixis; Ipsen; Merck; NiKang Therapeutics; Novartis
Research Funding - Arrowhead Pharmaceuticals (Inst); Aveo (Inst); Corvus Pharmaceuticals (Inst); Merck (Inst); NiKang Therapeutics (Inst)
Travel, Accommodations, Expenses - Pfizer